Cargando…
Synthesis, molecular docking, and in vivo antidiabetic evaluation of new benzylidene-2,4-thiazolidinediones as partial PPAR-γ agonists
Peroxisome proliferator-activated receptor-γ (PPAR-γ) partial agonists or antagonists, also termed as selective PPAR-γ modulators, are more beneficial than full agonists because they can avoid the adverse effects associated with PPAR-γ full agonists, such as weight gain and congestive heart disorder...
Autores principales: | Najmi, Asim, Alam, Md Shamsher, Thangavel, Neelaveni, Taha, Manal M. E., Meraya, Abdulkarim M., Albratty, Mohammed, Alhazmi, Hassan A., Ahsan, Waquar, Haque, Anzarul, Azam, Faizul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645977/ https://www.ncbi.nlm.nih.gov/pubmed/37963936 http://dx.doi.org/10.1038/s41598-023-47157-x |
Ejemplares similares
-
Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic Drugs
por: Thangavel, Neelaveni, et al.
Publicado: (2017) -
Perception of Individuals with Diabetes about Efficacy and Safety of Complementary and Alternative Medicines (CAM) in the Jazan Region, Saudi Arabia
por: Meraya, Abdulkarim M., et al.
Publicado: (2022) -
Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes
por: Yasmin, Sabina, et al.
Publicado: (2017) -
Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19
por: Alhazmi, Hassan A., et al.
Publicado: (2021) -
Alkaloidal Phytoconstituents for Diabetes Management: Exploring the Unrevealed Potential
por: Behl, Tapan, et al.
Publicado: (2022)